PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety

PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety

Abstract Background Triple negative breast cancer (TNBC) represents a particularly aggressive and clinically challenging subtype of breast cancer, characterized by its invasive nature and generally poor prognosis. Treatment options for unresectable TNBC are limited. In recent years, the advent of PD...

Full description

Saved in:
Bibliographic Details
Main Authors: Zuxiu Wang, Peimeng You, Zhanglei Yang, Hanxi Xiao, Xinrong Tang, Yongping Pan, Xuhuan Li, Feng Gao
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Cancer
Subjects:
Triple-negative breast cancer
PD-1/PD-L1 inhibitors
Systematic reviews
Meta-analysis
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-024-13105-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13105-9

Similar Items